Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry — Vincenzo Livio Malavasi (2022) | RDL Network
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry
Article 2022 en
Authors
VM
Vincenzo Livio Malavasi
MV
Marco Vitolo
MP
Marco Proietti
Abstract
1 min read
In a large contemporary cohort of AF patients, active malignancy was independently associated with all-cause death, MACE and haemorrhagic events. Use of anticoagulants was not associated with a higher risk of all-cause death in patients with active malignancies.
Marrco Vitolo, Vincenzo Livio Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Deirdre A. Lane, Professor Gregory Lip, Giuseppe Boriani
Giuseppe Boriani, M Vitolo, Marco Proietti, V L Malavasi, N Bonini, G F Romiti, J F Imberti, L Fauchier, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Aldo Maggioni, Deirdre A. Lane, G Y H Lip
Marco Proietti, Marco Vitolo, Stephanie L. Harrison, Gheorghe‐Andrei Dan, Aldo P. Maggioni, Tatjana Potpara, David A. Lane, Giuseppe Boriani, Professor Gregory Lip
Marco Vitolo, Marco Proietti, Stephanie L. Harrison, Zbigniew Kalarus, Luigi Tavazzi, Tatjana Potpara, Deirdre A. Lane, Giuseppe Boriani, Professor Gregory Lip
Giuseppe Boriani, Marco Proietti, C Laroche, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gaita Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.